Data / Form D filings / Grace Therapeutics, Inc.
Grace Therapeutics, Inc.: Form D filings
Grace Therapeutics, Inc., a pharmaceuticals company in Princeton, NJ, filed 5 Form D notices with the SEC between 2011 and 2026. The latest, on August 11, 2026, reports $10 million sold of a $10 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 103 CARNEGIE CENTER SUITE 300, Princeton, NJ, 08540
- Phone
- (609) 322-1602
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1444192
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | New notice | $9,999,998 | $9,999,998 | 9 | Aug 4, 2026 | sec.gov | |
| Feb 25, 2025 | New notice | $30,000,203 | $14,999,985 | $15,000,218 | 14 | Feb 10, 2025 | sec.gov |
| Oct 10, 2023 | New notice | $15,116,786 | $7,499,793 | $7,616,993 | 4 | Sep 25, 2023 | sec.gov |
| May 25, 2018 | New notice | $837,546 | $372,637 | $464,909 | 1 | May 9, 2018 | sec.gov |
| Sep 2, 2011 | New notice | Indefinite | $170,466 | 1 | Aug 18, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Prashant Kohli | Executive Officer, Director | Chief Executive Officer |
| Vimal Kavuru | Director | |
| Robert J. DelAversano | Executive Officer | Vice President, Finance, Principal Financial Officer and Principal Accounting Officer |
| A. Brian Davis | Director | |
| S. George Kottayil | Director | |
| Edward Neugeboren | Director | |
| Dr. R. Loch Macdonald | Executive Officer | Chief Medical Officer |
| Amresh Kumar | Executive Officer | VP of Program Management |
Every Form D from the week of Aug 10, 2026 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Grace Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.